Topics
Glioblastoma | Treatment | Radiotherapy | Hypofractionation
Home > Publications > Topics > Glioblastoma > Treatment > Radiotherapy > Hypofractionation
*Beckham
TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S,
Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W,
Ferguson S, Patel CB, Li J, Yeboa DN.
Hypofractionated
radiotherapy for glioblastoma: A large institutional retrospective
assessment of 2 approaches.
Neurooncol
Pract.
2024 Jan 18;11(3):266-274. doi:
10.1093/nop/npae004. PMID:
38737610. Observational study˰ ˍ
Almeida ND, Rupp J, Gulzar B, Schrand TV, Madhugiri V, Fang M,
Shekher R, Goulenko V, Goyal D, Prasad S, Milano MT, Prasad D.
Evaluating the impact of performance
status in elderly patients with glioblastoma.
J
Clin Neurosci. 2025 Jan 3;133:111028. doi:
10.1016/j.jocn.2024.111028. PMID:
39755030. Observational study. ˍ
Di Guglielmo FC, Bonaparte I, Davì
V, Guida P, Ciliberti MP, Gregucci F, Surgo A, Caliandro M,
Carbonara R, Giraldi D, Fanelli V, Surico G, Gentile MA, Calbi R,
Internò V, Laera L, Talienti T, Signorelli F, Lombardi G,
Fiorentino A.
Are
conventional and hypofractionated chemoradiotherapy comparable in
glioblastoma patients?
Clin
Transl Oncol.
2025 Nov 2. doi:
10.1007/s12094-025-04107-5. PMID:
41176740. Observational
study˰
ˍ
Chien DL, Hardy SJ, Serventi JN, Behr JM, Mohile NA, Hemminger LE.
Impact of radiation fractionation on
pseudoprogression in older patients with glioblastoma: a
retrospective cohort study.
CNS
Oncol. 2025 Nov 6;14(1):2584958. doi:
10.1080/20450907.2025.2584958. PMID:
41196722. Observational study. ˍ
Di Muzio N, Torrisi M, Barzaghi R, Pocaterra A, Mori M, Folchini
F, Giannini L, Valle M, Bailo M, Deantoni CL, Snider S, Gagliardi
F, Ruggiero E, Broggi S, Ruffino L, Di Franco R, Mercogliano S,
Fiorino C, Del Vecchio A, Muto M, Muto P, Mortini P, Mondino A,
Fodor A.
Neoadjuvant
ultrahypofractionated radiotherapy with simultaneous integrated
boost for glioblastoma: study protocol for a phase I multicenter
clinical trial.
BMC
Cancer. 2026 Apr 6;26(1):633. doi:
10.1186/s12885-026-15950-2. PMID:
41942944. Trial
registration ID: NCT06551909. ˍ
de Jong AM, van der Boog ATJ, Wester G, Eekers DBP, Budiharto TCG,
Rozema T, Lagerwaard FJ, Bruynzeel AME, de Groot C, van der Meulen
M, Cialdella F, Dankbaar JW, Hendrikse J, Kleynen KE, Claes A,
Philippens MEP, Smid EJ, de Vos FYFL, van Rossum PSN, Robe PA,
David S, Snijders TJ, Verhoeff JJC.
Ultra-hypofractionated
versus conventional chemoradiation for newly diagnosed
glioblastoma: Survival and toxicity results of a multicenter
randomized trial.
Radiother
Oncol. 2026 Aug 8;223:111726. doi:
10.1016/j.radonc.2026.111726. PMID:
42570798. Trial
registration ID: NL72953.041.20.
ˍ